Crestal Bone Response to Narrow vs. Regular Tie-Base in Subcrestal Implants

NCT ID: NCT07196228

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2028-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This 24-month randomized clinical trial evaluates peri-implant marginal bone changes at subcrestal implants restored with narrow versus regular tie-base abutments.

The study investigates whether narrow or regular tie-base abutments influence peri-implant crestal bone remodeling over 24 months.

This trial assesses the effect of abutment diameter (narrow vs. regular tie-base) on marginal bone stability at subcrestal implants after 24 months.

We aimed to determine if abutment diameter impacts peri-implant marginal bone levels by comparing narrow and regular tie-base abutments in a 24-month RCT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INTRODUCTION The preservation of supracrestal peri- implant soft tissues plays a crucial role in maintaining bone tissue stability.(1) In recent decades, it has been suggested that peri- implant marginal bone loss is influenced by several factors, including the surface characteristics of the implant neck, the implant- abutment, abutment height, platform switching, and abutment dis/reconnection.(2) Limiting these disconnections has been shown to improve the maintenance of the peri- implant marginal bone level.

On the other hand, it has been observed that transmucosal abutments with convex designs can influence bone remodeling, even with platform switching, when compared to straight or concave abutments.(3,4) The hypothesis was that distancing the abutment- prosthesis interface from the implant shoulder and using narrower transmucosal abutments with platform switching could favor the maintenance of the peri- implant marginal bone level by reducing bone remodeling and the apical migration of the "biological width".

Although there is evidence regarding the influence of platform switching or abutment height on the maintenance of the peri- implant marginal bone level, the evidence on the effect of abutment diameter is limited.(5,6) Therefore, the aim of this 24- month randomized clinical trial is to evaluate changes in the peri- implant marginal bone level at implants restored narrow or regular tie-base after 24 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Narrow tie-base abutment

Patients received subcrestal bone-level implants restored with narrow tie-base abutments.

Group Type EXPERIMENTAL

Intervention Name (Arm 1): Narrow tie-base abutment Intervention Name (Arm 2): Regular tie-base abutment

Intervention Type DEVICE

Arm 1 - Narrow tie-base abutment

Intervention Name: Narrow tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a narrow-diameter tie-base abutment.

Arm 2 - Regular tie-base abutment

Intervention Name: Regular tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a regular-diameter tie-base abutment.

Regular tie-base abutment

Patients received subcrestal bone-level implants restored with regular tie-base abutments.

Group Type PLACEBO_COMPARATOR

Intervention Name (Arm 1): Narrow tie-base abutment Intervention Name (Arm 2): Regular tie-base abutment

Intervention Type DEVICE

Arm 1 - Narrow tie-base abutment

Intervention Name: Narrow tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a narrow-diameter tie-base abutment.

Arm 2 - Regular tie-base abutment

Intervention Name: Regular tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a regular-diameter tie-base abutment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Name (Arm 1): Narrow tie-base abutment Intervention Name (Arm 2): Regular tie-base abutment

Arm 1 - Narrow tie-base abutment

Intervention Name: Narrow tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a narrow-diameter tie-base abutment.

Arm 2 - Regular tie-base abutment

Intervention Name: Regular tie-base abutment

Intervention Type: Device

Intervention Description: Participants received a subcrestal bone-level dental implant restored with a regular-diameter tie-base abutment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adults ≥18 years old.

Single missing tooth in a posterior quadrant, bordered by adjacent natural teeth.

Adequate bone volume to place implants 8.5-10 mm in length and 4 mm in diameter without the need for bone or soft tissue grafting.

Presence of a natural tooth or an implant-supported fixed restoration as an antagonist.

Good oral hygiene with a plaque index \<25%.

Willing and able to comply with study procedures and follow-up schedule.

Provided written informed consent.

Exclusion Criteria

Systemic conditions or medications affecting bone metabolism (e.g., bisphosphonates, corticosteroids).

Untreated periodontitis, persistent oral infections, or poor oral hygiene.

Metabolic bone diseases (e.g., osteoporosis, renal insufficiency, immunodeficiency, leukocyte dysfunction).

History of head and neck radiotherapy.

Physical or mental disability preventing adequate oral hygiene or compliance.

Heavy smoking (\>10 cigarettes/day).

Alcoholism or drug abuse.

Pregnancy or breastfeeding.

Bruxism or oral mucosal diseases.

Need for bone regeneration procedures before implant placement.

Inability or unwillingness to attend follow-up visits.
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role collaborator

Menoufia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammed El-Sawy

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohammed El-Sawy, PhD

Role: CONTACT

00201061314522

Mohammed T. Khater, PhD

Role: CONTACT

00201003854552

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ADMNF-00425

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.